# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3361957 | B | Agonist activity at human TAS2R41 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
2. | ALA4346435 | F | Antagonist activity at recombinant human TAS2R41 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of picric acid-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dye based FLIPR assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
3. | ALA4419016 | F | Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R41 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
4. | ALA4419220 | F | Agonist activity at human TAS2R41 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level by Calcium-3 dye based fluorescence assay | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
5. | ALA4419245 | F | Agonist activity at human TAS2R41 expressed in HEK293T cells co-expressing Galpha15 assessed as increase in intracellular calcium level at 20 mM by Calcium-3 dye based fluorescence assay relative to control | Homo sapiens | 3 | cell-based format | Patent Bioactivity Data | ||
6. | ALA4421753 | F | Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R41 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as effect on intracellular calcium level at 100 uM by FLIPR assay | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
7. | ALA4482402 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 80 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.146471 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
8. | ALA4482403 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 75 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.132941 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
9. | ALA4482404 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 70 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.152941 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
10. | ALA4482405 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 65 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.138235 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
11. | ALA4482406 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 60 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.145294 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
12. | ALA4482407 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 55 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.168235 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
13. | ALA4482408 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 50 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.167647 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
14. | ALA4482409 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 45 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.176471 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
15. | ALA4482410 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 40 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.171765 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
16. | ALA4482411 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 35 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.167647 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
17. | ALA4482412 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 30 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.166471 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
18. | ALA4482413 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-5) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 25 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.158824 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
19. | ALA4482414 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-7) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 80 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.146471 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data | ||
20. | ALA4482415 | F | Agonist activity at N-terminal rat ST3 receptor-fused full length human TAS2R41 (nucleotide sequence ID No-7) expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level by measuring deltaF/F0 ratio level at 75 mM by Fluo-4AM dye based FLIPR assay (Rvb = 0.132941 No_unit) | Homo sapiens | 1 | cell-based format | Patent Bioactivity Data |